Laman Utama207940 • KRX
add
Samsung Biologics Co Ltd
Tutup sebelumnya
₩1,034,000.00
Julat hari
₩1,015,000.00 - ₩1,040,000.00
Julat tahun
₩722,000.00 - ₩1,209,000.00
Permodalan pasaran
72.53T KRW
Bilangan Purata
80.03K
Nisbah P/E
56.68
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.30T | 37.11% |
Perbelanjaan pengendalian | 241.41B | 22.51% |
Pendapatan bersih | 375.55B | 109.38% |
Margin untung bersih | 28.93 | 52.75% |
Pendapatan bagi setiap syer | 5.28K | 109.40% |
EBITDA | 650.09B | 78.25% |
Kadar cukai berkesan | 24.80% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.29T | -37.61% |
Jumlah aset | 17.44T | 5.53% |
Jumlah liabiliti | 6.16T | -5.47% |
Jumlah ekuiti | 11.28T | — |
Syer tertunggak | 71.17J | — |
Harga kepada buku | 6.52 | — |
Pulangan pada aset | 7.00% | — |
Pulangan pada modal | 9.70% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 375.55B | 109.38% |
Tunai daripada operasi | 682.98B | 135.64% |
Tunai daripada pelaburan | -250.22B | -142.78% |
Tunai daripada pembiayaan | -69.80B | 65.49% |
Perubahan bersih dalam tunai | 360.84B | -47.87% |
Aliran tunai bebas | -103.14B | -115.61% |
Perihal
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
CEO
Diasaskan
2011
Tapak web
Pekerja
4,770
